I recently shot an email off to Martin Rogers , CEO of PRR.
As usual he kindly replied...
below are a list of the questions... with MR's answers.
Hi Martin,
I am a very happy PRR shareholder . I have emailed you in the past and have really appreciated your responses.
Congratulations on a most successful Capital Raising. You must be most pleased that your hard work is paying off.
I will be participating in the SPP and hope to receive a full allocation.
All sounds like it's full steam ahead and as shareholders can I relay that we are really enjoying the ' ride' to date.
There appears to be some confusion as to the ' mechanics ' of how the Nasdaq / ADR ' works' .
___________________
Question 1.
When will the Marketmaker BNYM be likely to purchase shares for the American Investors... will this be before the Nasdaq listing or after the listing ?
Answer
" 1.Market maker will purchase shares when the SEC clears the process. There is typically 10 days for this to happen before the NASDAQ listing becomes effective. "
______________________
Question 2.
How many PRR shares will be available for trading on the Nasdaq ?
Answer
" 2. This is upto the market maker to decide "
____________________
Question 3.
Are shares sold on the Nasdaq then purchased from the ASX PRR shares the next day ?
Answer
" 3.This is again a decision for the market maker to decide as they probably want to balance any currency or T+3 risk "
___________________
Question 4.
Does the market maker sell shares ' backwards and forwards ' between the 2 exchanges ?
Answer
" 4. Yes
___________________
Question 5.
When do you anticipate CVac being available ' commercially ' in Australia
Answer
"5. Before the US FDA approval "
______________________
Question 6.
Do you have any more rabbits to pull out of your hat like the cap raising and the ' Duabi medical centre announcement ?
Answer
" 6. I would answer this to say it is a pleasure to provide a much needed cancer vaccine for cancer patients "
_______________________
"Thank you for your support we couldn?t do the great work are doing without the support from investors.
Best regards,
Martin Rogers
Chief Executive Officer "
Prima BioMed Ltd "
- Forums
- ASX - By Stock
- IMM
- prima biomed - nasdaq 101
prima biomed - nasdaq 101, page-3
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
30.5¢ |
Change
-0.010(3.17%) |
Mkt cap ! $443.6M |
Open | High | Low | Value | Volume |
31.0¢ | 31.8¢ | 30.5¢ | $1.050M | 3.399M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 334744 | 30.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 5285 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 334744 | 0.305 |
25 | 429113 | 0.300 |
9 | 120834 | 0.295 |
11 | 509636 | 0.290 |
9 | 1056625 | 0.285 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 5285 | 1 |
0.315 | 7174 | 2 |
0.320 | 115546 | 6 |
0.325 | 239718 | 4 |
0.330 | 26299 | 3 |
Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online